Together, our findings reveal that PTBP3 modulates exon skipping of IL‐18 to promote immune escape in gallbladder cancer, providing a new perspective for gallbladder cancer immunotherapy by blocking ΔIL‐18 production. Here, IL18 is linked to gallbladder cancer.